A Phase I, Open, Randomised, Single-Centre, Crossover Study to Assess the Absorption, Distribution, Metabolism and Excretion (ADME) After Oral and Intravenous Administration of 14C-Labelled and Non-Labelled AZD1305 to Healthy Male Volunteers
Phase of Trial: Phase I
Latest Information Update: 26 Aug 2008
At a glance
- Drugs AZD 1305; AZD 1305
- Indications Atrial fibrillation
- Focus Pharmacokinetics
- 26 Aug 2008 Actual end date (May 2008) added as reported by ClinicalTrials.gov.
- 28 Jun 2008 New trial record.